Lilly to collaborate with Precision BioSciences on genome editing research
Lead programme will focus on developing therapies for Duchenne muscular dystrophy
Read More
Tag: Genome editing
Genome editing successful in correcting muscular dystrophy in mice
Researchers at Duke University have shown that CRISPR genome editing technology can safely and stably correct Duchenne muscular dystrophy in mice.
Read More
Allergan signs up to Editas’ genome editing tech
Allergan has secured itself exclusive access to Editas Medicine’s genome-editing ocular programmes under a strategic research and development pact between the two firms.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
